Publications

5808 Results

Phase II trial of edatrexate plus carboplatin in metastatic non-small cell lung cancer: A Southwest Oncology Group study.

Authors
DR Gandara;MJ Edelman;JJ Crowley;RB Livingston
Journal / Conference
Cancer Chemotherapy and Pharmacology 41:75-78
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-9207

Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.

Authors
CP Leith;KJ Kopecky;J Godwin;T McConnell;ML Slovak;I Chen;DR Head;FR Appelbaum;CL Willman
Journal / Conference
Blood 89(9):3323-3329
Year
1997
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007, SWOG-9031

Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: A Southwest Oncology Group study.

Authors
RP Whitehead;J Jacobson;TD Brown;SA Taylor;GR Weiss;JS Macdonald
Journal / Conference
Journal of Clinical Oncology 15(6):2414-2419
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9135

Significant long-term patient benefit with BCG maintenance therapy: A Southwest Oncology Group study.

Authors
DL Lamm;B Blumenstein;M Sarosdy;HB Grossman;ED Crawford
Journal / Conference
Journal of Urology 157(4)Suppl:213(#831)
Year
1997
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Comparison of bilateral orchiectomy with or without flutamide for the treatment of patients (pts) with stage D2 adenocarcinoma of the prostate (CaP): Results of NCI Intergroup study 0105 (SWOG and ECOG).

Authors
ED Crawford;MA Eisenberger;DG McLeod;G Wilding;BA Blumenstein
Journal / Conference
Journal of Urology 157(4):336(#1311)
Year
1997
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.

Authors
CS Higano;JJ Crowley;RV Veith;RB Livingston
Journal / Conference
Investigational New Drugs 15:153-156
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-9058

Immunologic reconstitution following adjuvant 5FU and levamisole (LMS) correlates with disease free survival in stage III colon cancer: Report of Southwest Oncology Group (SWOG) protocol #9009.

Authors
RF Holcombe;J Jacobson;JS Macdonald;SR Dakhil;RM Stewart;KS Betzing;K Kannan
Journal / Conference
Proc of the American Association for Cancer Research 38:521(#3494)
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9009

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor positive metastatic breast cancer: A Southwest Oncology Group phase III trial.

Authors
CA Russell;SJ Green;J O'Sullivan;HE Hynes;GT Budd;JE Congdon;S Martino;CK Osborne
Journal / Conference
Journal of Clinical Oncology 15(7):2494-2501
Year
1997
Research Committee(s)
Breast
Study Number(s)
SWOG-8312

Tamoxifen (T) versus cyclophosphamide, adriamycin and 5-FU plus either concurrent or sequential T in postmenopausal, receptor(+), node(+) breast cancer: a Southwest Oncology Group phase III intergroup trial (SWOG-8814, INT-0100).

Authors
K Albain;S Green;K Osborne;C Cobau;E Levine;J Ingle;K Pritchard;D Schneider;J O'Sullivan;E Hess;S Martino
Journal / Conference
Proc of the American Society of Clinical Oncology 16:128a(#450)
Year
1997
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Concurrent cisplatin/etoposide plus radiotherapy (PE+RT) for pathologic stage (pathTN) IIIB non-small cell lung cancer(NSCLC): a Southwest Oncology Group (SWOG) phase II study (S9019).

Authors
KS Albain;JJ Crowley;AT Turrisi III;DR Gandara;WB Farrar;J Clark;KR Beasley;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 16:446a(#1600)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-9019